[Dipropylacetate (sodium valproate) and carbamazepine : a suspicious anticonvulsant combination].
D002220:Carbamazepine / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D003221:Confusion / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D014635:Valproic Acid / Q000009:adverse effects*
D002220:Carbamazepine; D014635:Valproic Acid
Dipropylacétate (valproate de sodium) et carbamazépine: une association antiépileptique suspecte.